Brokerages expect RTI Surgical, Inc. (NASDAQ:RTIX) to post $66.27 million in sales for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided estimates for RTI Surgical’s earnings, with the highest sales estimate coming in at $66.28 million and the lowest estimate coming in at $66.25 million. RTI Surgical posted sales of $66.55 million during the same quarter last year, which suggests a negative year-over-year growth rate of 0.4%. The company is scheduled to announce its next earnings report on Tuesday, October 24th.

According to Zacks, analysts expect that RTI Surgical will report full year sales of $66.27 million for the current financial year, with estimates ranging from $277.80 million to $278.75 million. For the next financial year, analysts expect that the business will report sales of $282.01 million per share, with estimates ranging from $281.68 million to $282.33 million. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side analysts that follow RTI Surgical.

RTI Surgical (NASDAQ:RTIX) last issued its earnings results on Tuesday, August 8th. The medical equipment provider reported $0.02 EPS for the quarter, hitting the Zacks’ consensus estimate of $0.02. The business had revenue of $72.10 million for the quarter, compared to the consensus estimate of $70.25 million. RTI Surgical had a negative net margin of 6.53% and a positive return on equity of 2.07%. RTI Surgical’s quarterly revenue was up 6.7% compared to the same quarter last year.

A number of equities research analysts have weighed in on RTIX shares. ValuEngine upgraded shares of RTI Surgical from a “sell” rating to a “hold” rating in a research report on Friday, June 2nd. Zacks Investment Research upgraded shares of RTI Surgical from a “hold” rating to a “buy” rating and set a $6.25 price target for the company in a research report on Wednesday, June 28th. Finally, BidaskClub cut shares of RTI Surgical from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, July 25th.

In other RTI Surgical news, Director Nicholas J. Valeriani acquired 5,500 shares of the company’s stock in a transaction that occurred on Monday, August 21st. The stock was purchased at an average price of $4.70 per share, for a total transaction of $25,850.00. Following the completion of the acquisition, the director now owns 47,754 shares of the company’s stock, valued at approximately $224,443.80. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP John N. Varela acquired 12,000 shares of the company’s stock in a transaction that occurred on Friday, August 11th. The stock was acquired at an average price of $4.85 per share, with a total value of $58,200.00. Following the acquisition, the executive vice president now directly owns 47,998 shares of the company’s stock, valued at approximately $232,790.30. The disclosure for this purchase can be found here. 4.90% of the stock is owned by company insiders.

Hedge funds have recently made changes to their positions in the stock. Geode Capital Management LLC grew its holdings in shares of RTI Surgical by 3.7% in the first quarter. Geode Capital Management LLC now owns 456,346 shares of the medical equipment provider’s stock valued at $1,825,000 after purchasing an additional 16,235 shares in the last quarter. Russell Investments Group Ltd. grew its holdings in shares of RTI Surgical by 176.0% in the first quarter. Russell Investments Group Ltd. now owns 78,055 shares of the medical equipment provider’s stock valued at $313,000 after purchasing an additional 49,777 shares in the last quarter. Nine Chapters Capital Management LLC grew its holdings in shares of RTI Surgical by 75.9% in the first quarter. Nine Chapters Capital Management LLC now owns 35,000 shares of the medical equipment provider’s stock valued at $140,000 after purchasing an additional 15,100 shares in the last quarter. Bank of New York Mellon Corp grew its holdings in shares of RTI Surgical by 3.5% in the first quarter. Bank of New York Mellon Corp now owns 255,656 shares of the medical equipment provider’s stock valued at $1,022,000 after purchasing an additional 8,679 shares in the last quarter. Finally, Kennedy Capital Management Inc. grew its holdings in shares of RTI Surgical by 20.0% in the first quarter. Kennedy Capital Management Inc. now owns 1,422,371 shares of the medical equipment provider’s stock valued at $5,689,000 after purchasing an additional 236,923 shares in the last quarter. Hedge funds and other institutional investors own 69.99% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “RTI Surgical, Inc. (RTIX) Expected to Announce Quarterly Sales of $66.27 Million” was first reported by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another domain, it was stolen and republished in violation of international copyright & trademark legislation. The original version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/09/10/rti-surgical-inc-rtix-expected-to-announce-quarterly-sales-of-66-27-million.html.

RTI Surgical (NASDAQ:RTIX) opened at 4.45 on Friday. The firm has a 50-day moving average of $4.99 and a 200-day moving average of $4.68. RTI Surgical has a 52 week low of $2.50 and a 52 week high of $6.00. The company’s market capitalization is $262.70 million.

RTI Surgical Company Profile

RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.

Get a free copy of the Zacks research report on RTI Surgical (RTIX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for RTI Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.